TITLE

Taking Antiretroviral Therapy for HIV Infection

AUTHOR(S)
Laws, M. Barton; Wilson, Ira B.; Bowser, Diana M.; Kerr, Sarah E.
PUB. DATE
December 2000
SOURCE
JGIM: Journal of General Internal Medicine;Dec2000, Vol. 15 Issue 12, p848
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To describe how people with HIV understand and experience the problem of adhering to antiretroviral medication regimens. DESIGN: We performed a qualitative study based on interviews with HIV-infected patients, including 46 clients of AIDS service organizations, who were sampled according to age, ethnicity, and injection drug use history, and a convenience sample of 15 patients. Interviews were conducted in English or Spanish and were audiotaped and transcribed. PARTICIPANTS: Of 52 respondents who had prescriptions for antiretroviral therapy, 25 were randomly selected for in-depth analysis. Of these, 5 reported having an AIDS diagnosis, 15 reported symptoms they attributed to HIV, and 5 reported having no symptoms of HIV disease. MEASUREMENTS AND MAIN RESULTS: Investigators prepared structured abstracts of interviews to extract adherence-related data. One investigator compared the abstracts with the original transcripts to confirm the interpretations, and used the abstracts to organize and classify the findings. Most subjects (84%) reported recent non-adherent behavior, including ceasing treatment, medication "holidays," sleeping through doses, forgetting doses, skipping doses due to side effects, and following highly asymmetric schedules. Initially, most reported that they were not significantly non-adherent, and many did not consider their behavior non-adherent. Only a minority clearly understood the possible consequences of missing doses. Most said they had not discussed their non-adherence with their physicians. CONCLUSIONS: Many people rationalize their difficulty in adhering to HIV treatment by deciding that the standard of adherence they can readily achieve is appropriate. Physicians should inquire about adherence-related behavior in specific detail, and ensure that patients understand the consequences of not meeting an appropriate standard.
ACCESSION #
6000200

 

Related Articles

  • Reduced adherence to antiretroviral therapy among patients on antiretroviral therapy in Limpopo province, South Africa. MAKUA, T. // African Journal for Physical, Health Education, Recreation & Dan;2015Supplement, Vol. 21, p107 

    The purpose of this study was to explore the determining factors for reduced adherence to antiretroviral therapy (ART) for HIV positive patients on ART residing in Polokwane, in Limpopo Province of South Africa. This study made use of the generic qualitative research design and in-depth...

  • A prospective study of predictors of adherence to combination antiretroviral medication. Golin, Carol E.; Liu, Honghu; Hays, Ron D.; Miller, Loren G.; Beck, C. Keith; Ickovics, Jeanette; Kaplan, Andrew H.; Wenger, Neil S. // JGIM: Journal of General Internal Medicine;Oct2002, Vol. 17 Issue 10, p756 

    Objective: Adherence to complex antiretroviral therapy (ART) is critical for HIV treatment but difficult to achieve. The development of interventions to improve adherence requires detailed information regarding barriers to adherence. However, short follow-up and inadequate adherence...

  • Patient Adherence To HAART Regimens: Challenges For Physician Assistants And Health Care Providers. Day, Marvin // Internet Journal of Academic Physician Assistants;2003, Vol. 3 Issue 1, p42 

    Patients often adhere incompletely and inadequately to highly active antiretroviral therapy (HAART) regimens used in the treatment of HIV infection. This permits the emergence of HIV variants that are resistant to current treatment. The physician assistant often assumes the responsibility for...

  • Efectos del tiempo de infección sobre predictores de adherencia en personas con VIH. Piña López, Julio Alfonso; Tapia, Mariana Dávila; Sánchez Sosa, Juan José; Robles, Óscar Cázares; Togawa, Carlos; Corrales Rascón, Andrés Ernesto // International Journal of Psychology & Psychological Therapy;2009, Vol. 9 Issue 1, p67 

    A cross-sectional study was made with the main objective to prove the effects of length of infection (in months) on predictors of adherence behaviors to antiretroviral therapy in a sample of 44 persons with HIV. A multiple linear regression analysis showed that motives and stress-related to high...

  • Factors Affecting Adherence to Antiretroviral Therapy. Chesney, Margaret A. // Clinical Infectious Diseases;6/1/2000 Supplement 2, Vol. 30, pS171 

    Enumerates the factors that influence adherence to antiretroviral therapy for treating HIV infections. Patient factors; Medication regimen; Patient-health care provider relationship; System of care; Reasons reported by HIV-infected individuals for not taking their medications.

  • Case Management Is Associated with Improved Antiretroviral Adherence and CD4+ Cell Counts in Homeless and Marginally Housed Individuals with HIV Infection. Kushel, M. B.; Colfax, G.; Ragland, K.; Heineman, A.; Palacio, H.; Bangsberg, D. R. // Clinical Infectious Diseases;7/15/2006, Vol. 43 Issue 2, p234 

    Background. Case management (CM) coordinates care for persons with complex health care needs. It is not known whether CM is effective at improving biological outcomes among homeless and marginally housed persons with human immunodeficiency virus (HIV) infection. Our goal was to determine whether...

  • Applying the Information-Motivation-Behavioral Skills Model in Medication Adherence Among Thai Youth Living with HIV: A Qualitative Study. Rongkavilit, Chokechai; Naar-King, Sylvie; Kaljee, Linda M.; Panthong, Apirudee; Koken, Juline A.; Bunupuradah, Torsak; Parsons, Jeffrey T. // AIDS Patient Care & STDs;Dec2010, Vol. 24 Issue 12, p787 

    With disproportionately higher rates of HIV/AIDS among youth and increasing access to antiretroviral therapy (ART) in Thailand, there is a growing urgency in understanding the challenges to medication adherence confronting this population and in developing theory-based interventions to address...

  • Neuropsychiatric Adverse Events With Ritonavir-Boosted Darunavir Monotherapy in HIV-Infected Individuals: A Randomised Prospective Study. Winston, Alan; Fätkenheuer, Gerd; Arribas, Jose; Hill, Andrew; van Delft, Yvon; Moecklinghoff, Christiane // HIV Clinical Trials;May/Jun2010, Vol. 11 Issue 3, p163 

    Background: Protease inhibitor monotherapy is an attractive treatment option for HIV-infected subjects. Data assessing neuropsychiatric events with the use of protease inhibitor monotherapy are sparse. Methods: Clinician- and patient-reported neuropsychiatric events were assessed over 48 weeks...

  • Management of the Adverse Effects of Antiretroviral Therapy and Medication Adherence. Max, Blake; Sherer, Renslow // Clinical Infectious Diseases;6/1/2000 Supplement 2, Vol. 30, pS96 

    Examines the therapeutic agents included in the highly active antiretroviral therapy (HAART) for the treatment of patients with HIV infections. Link between poor adherence and failure of antiretroviral therapy; Threat of short term-adverse effects to successful introduction and maintenance of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics